{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:11:52Z","timestamp":1791357112918,"version":"4.3.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.jad.2012.07.016","type":"journal-article","created":{"date-parts":[[2012,8,21]],"date-time":"2012-08-21T12:37:01Z","timestamp":1345552621000},"page":"83-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Randomized, placebo-controlled trial of quetiapine XR and divalproex ER monotherapies in the treatment of the anxious bipolar patient"],"prefix":"10.1016","volume":"145","author":[{"given":"David V.","family":"Sheehan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Harnett-Sheehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario B.","family":"Hidalgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juris","family":"Janavs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L.","family":"McElroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darlene","family":"Amado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trisha","family":"Suppes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jad.2012.07.016_bib1","first-page":"439","article-title":"Emergence of obsessive-compulsive symptoms during treatment with clozapine","volume":"53","author":"Baker","year":"1992","journal-title":"Journal of Clinical Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2012.07.016_bib2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1017\/S1461145709990423","article-title":"Once-daily extended release quetiapine fumarate (quetiapine XR) monotherapy in generalized anxiety disorder (GAD). Data from a randomized, double-blind, placebo and active-controlled study","volume":"13","author":"Bandelow","year":"2010","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2012.07.016_bib3","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","article-title":"A rating scale for drug induced akathisia","volume":"154","author":"Barnes","year":"1989","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.jad.2012.07.016_bib4","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.4088\/JCP.v65n0813","article-title":"Impact of comorbid anxiety disorders on outcome in a cohort of patients with bipolar disorder","volume":"65","author":"Boylan","year":"2004","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2012.07.016_bib5","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0022-3956(03)00052-9","article-title":"Early age at onset as a risk factor for poor outcome of bipolar disorder","volume":"37","author":"Carter","year":"2003","journal-title":"Journal of Psychiatric Research"},{"issue":"3","key":"10.1016\/j.jad.2012.07.016_bib6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1601-5215.2009.00378.x","article-title":"Safety tolerability and efficacy of a rapid dose escalation of quetiapine in bipolar I mania: The FATIMA study","volume":"21","author":"Constant","year":"2009","journal-title":"Acta Neuropsychiatrica"},{"issue":"1","key":"10.1016\/j.jad.2012.07.016_bib7","first-page":"26","article-title":"Sheehan Suicidality Tracking Scale (Sheehan\u2014STS): preliminary results from a multicenter clinical trial in generalized anxiety disorder","volume":"6","author":"Coric","year":"2009","journal-title":"Psychiatry (Edgemont)"},{"issue":"3","key":"10.1016\/j.jad.2012.07.016_bib8","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jad.2004.09.009","article-title":"Divalprex in the treatment of bipolar depression: a placebo controlled study","volume":"85","author":"Davis","year":"2005","journal-title":"Journal of Affective Disorders"},{"issue":"2","key":"10.1016\/j.jad.2012.07.016_bib9","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4088\/JCP.v63n0203","article-title":"Obsessive-compulsive symptoms during treatment with olanzapine and risperidone: prospective study of 11 patients with recent-onset schizophrenia or related disorders","volume":"63","author":"de Haan","year":"2002","journal-title":"Journal of Clinical Psychiatry"},{"issue":"40","key":"10.1016\/j.jad.2012.07.016_bib10","first-page":"1","article-title":"Atypical antipsychotics in bipolar disorder: systematic review of randomized trials, 2007","volume":"7","author":"Derry","year":"2007","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jad.2012.07.016_bib11","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jad.2006.07.008","article-title":"Dose\u2013response relationship between number of comorbid anxiety disorders in adolescent bipolar\/unipolar disorders, and psychosis, suicidality, substance abuse and familiality","volume":"96","author":"Dilsaver","year":"2006","journal-title":"Journal of Affective Disorders"},{"issue":"6","key":"10.1016\/j.jad.2012.07.016_bib12","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1176\/appi.ajp.157.6.956","article-title":"Anxiety as a correlate of response to the acute treatment of bipolar I disorder","volume":"157","author":"Feske","year":"2000","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jad.2012.07.016_bib13","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1001\/archpsyc.59.10.905","volume":"59","author":"Frank","year":"2002","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jad.2012.07.016_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-0327(00)00299-8","article-title":"The comorbidity of bipolar and anxiety disorders: prevalence, psychobiology and treatment issues","volume":"68","author":"Freeman","year":"2002","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.jad.2012.07.016_bib15","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1176\/appi.ajp.160.5.883","article-title":"Gender differences in prevalence, risk, and clinical correlates of alcoholism comorbidity in bipolar disorder","volume":"160","author":"Frye","year":"2003","journal-title":"American Journal of Psychiatry"},{"issue":"9","key":"10.1016\/j.jad.2012.07.016_bib16","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.4088\/JCP.v67n0902","article-title":"Efficacy of typical and second generation antipsychotics for primary and comorbid anxiety symptoms or disorders\u2014a review","volume":"67","author":"Gao","year":"2006","journal-title":"Journal of Clinical Psychiatry"},{"issue":"6","key":"10.1016\/j.jad.2012.07.016_bib17","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1046\/j.1399-5618.2003.00074.x","article-title":"Antidepressanets in bipolar disorder: the case for caution","volume":"5","author":"Ghaemi","year":"2003","journal-title":"Bipolar Disorders"},{"key":"10.1016\/j.jad.2012.07.016_bib18","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1176\/ps.2006.57.5.660","article-title":"Pharmacological treatment patterns at study entry for the first 500 STEP-BD participants","volume":"57","author":"Ghaemi","year":"2006","journal-title":"Psychiatric Services"},{"key":"10.1016\/j.jad.2012.07.016_bib19","series-title":"ECDEU Assessment Manual for Psychopharmacology. Revised for Mental Health. DHEW Pub (ADM)","author":"Guy","year":"1976"},{"key":"10.1016\/j.jad.2012.07.016_bib20","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"British Journal of Medical Psychology"},{"issue":"3","key":"10.1016\/j.jad.2012.07.016_bib21","doi-asserted-by":"crossref","first-page":"331","DOI":"10.4088\/JCP.v64n0316","article-title":"Anxiety disorders in 318 bipolar patients: prevalence and impact on illness severity and response to mood stabilizer","volume":"64","author":"Henry","year":"2003","journal-title":"Journal of Clinical Psychiatry"},{"issue":"7","key":"10.1016\/j.jad.2012.07.016_bib22","doi-asserted-by":"crossref","first-page":"841","DOI":"10.4088\/JCP.v64n0717","article-title":"The safety and early efficacy of oral-loaded divalproex versus standard-titration divalproex, lithium, olanzapine, and placebo in the treatment of acute mania associated with bipolar disorder","volume":"64","author":"Hirschfeld","year":"2003","journal-title":"Journal of Clinical Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2012.07.016_bib23","doi-asserted-by":"crossref","first-page":"355","DOI":"10.4088\/JCP.v67n0304","article-title":"Quetiapine in the treatment of anxiety in patients with bipolar I or II depression: a secondary analysis from a randomized, double-blind, placebo-controlled study","volume":"67","author":"Hirschfeld","year":"2006","journal-title":"Journal of Clinical Psychiatry"},{"issue":"7","key":"10.1016\/j.jad.2012.07.016_bib24","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/0006-3223(93)90010-B","article-title":"Valproate treatment of panic disorder and lactate-induced panic attacks","volume":"33","author":"Keck","year":"1993","journal-title":"Biological Psychiatry"},{"issue":"6","key":"10.1016\/j.jad.2012.07.016_bib25","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archpsyc.62.6.617","article-title":"Prevalence, severity, and comorbidity of twelve-month DSM-IV disorders in the National Comorbidity Survey Replication (NCS-R)","volume":"62","author":"Kessler","year":"2005","journal-title":"Archives of General Psychiatry"},{"issue":"5","key":"10.1016\/j.jad.2012.07.016_bib26","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1017\/S0033291797005333","article-title":"The epidemiology of DSM-III-R bipolar I disorder in a general population survey","volume":"27","author":"Kessler","year":"1997","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.jad.2012.07.016_bib27","unstructured":"Khan, A, Joyce, M, Eggens, I., et al., 2008. Extended release quetiapine fumarate (quetiapine XR): a once daily monotherapy in the treatment of patients with generalized anxiety disorder (GAD). Paper presented at: Anxiety Disorders Association of America Congress. March 6\u20139, 2008, Savannah, GA."},{"issue":"2","key":"10.1016\/j.jad.2012.07.016_bib28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2190\/T8EM-C8YH-373N-1UWD","article-title":"Assessing psychiatric impairment in primary care with the Sheehan Disability Scale","volume":"27","author":"Leon","year":"1997","journal-title":"International Journal of Psychiatry in Medicine"},{"key":"10.1016\/j.jad.2012.07.016_bib29","doi-asserted-by":"crossref","first-page":"164A","DOI":"10.1016\/0006-3223(90)90356-7","article-title":"Divalproex sodium's antipanic effect in panic disorder: a placebo-controlled study","volume":"27","author":"Lum","year":"1990","journal-title":"Biological Psychiatry"},{"issue":"5","key":"10.1016\/j.jad.2012.07.016_bib30","first-page":"215","article-title":"Quetiapine monotherapy as treatment for anxiety symptoms in patients with bipolar depression: a pooled analysis of results from 2 double-blind, randomized placebo-controlled studies","volume":"11","author":"Lydiard","year":"2009","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2012.07.016_bib31","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0006-3223(96)00299-5","article-title":"Panic disorder with familial bipolar disorder","volume":"42","author":"MacKinnon","year":"1997","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.jad.2012.07.016_bib32","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1176\/appi.ajp.160.9.1696","article-title":"Association of rapid mood switching with panic disorder and familial panic risk in familial bipolar disorder","volume":"160","author":"MacKinnon","year":"2003","journal-title":"American Journal of Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2012.07.016_bib33","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1176\/appi.ajp.158.3.420","article-title":"Axis I psychiatric comorbidity and its relationship to historic illness variables in 288 patients with bipolar disorder","volume":"158","author":"McElroy","year":"2001","journal-title":"American Journal of Psychiatry"},{"issue":"suppl 2","key":"10.1016\/j.jad.2012.07.016_bib34","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1399-2406.2003.00061.x","article-title":"The role of atypical antipsychotics in bipolar depression and anxiety disorders","volume":"5","author":"McIntyre","year":"2003","journal-title":"Bipolar Disorders"},{"issue":"3","key":"10.1016\/j.jad.2012.07.016_bib35","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.genhosppsych.2005.02.001","article-title":"Rapid oral loading of extended release divalproex in patients with acute mania","volume":"27","author":"Miller","year":"2005","journal-title":"General Hospital Psychiatry"},{"key":"10.1016\/j.jad.2012.07.016_bib36","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.jad.2012.07.016_bib37","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0165-0327(02)00120-9","article-title":"Differentiating moderate and severe depression using the Montgomery-\u00c5sberg depression rating scale (MADRS)","volume":"77","author":"Muller","year":"2003","journal-title":"Journal of Affective Disorders"},{"issue":"1\u20132","key":"10.1016\/j.jad.2012.07.016_bib38","first-page":"185","article-title":"Demographic and clinical features of panic disorder comorbid with bipolar I disorder: a 3-year retrospective study","volume":"106","author":"Nardi","year":"2007","journal-title":"Journal of Affective Disorders"},{"issue":"suppl 3","key":"10.1016\/j.jad.2012.07.016_bib39","first-page":"37","article-title":"The role of pharmacologic treatment guidelines for bipolar disorder","volume":"66","author":"Perlis","year":"2005","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2012.07.016_bib40","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.biopsych.2004.01.022","article-title":"Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD)","volume":"55","author":"Perlis","year":"2004","journal-title":"Biological Psychiatry"},{"issue":"10","key":"10.1016\/j.jad.2012.07.016_bib41","first-page":"31","article-title":"Bipolarity presenting as anxiety disorders","volume":"11","author":"Perugi","year":"2004","journal-title":"Primary Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.jad.2012.07.016_bib42","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0165-0327(96)01405-X","article-title":"Prevalence of anxiety disorders comorbidity in bipolar depression, unipolar depression and dysthymia","volume":"42","author":"Pini","year":"1997","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.jad.2012.07.016_bib43","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1176\/appi.ajp.159.1.23","article-title":"Catechol O-Methyltransferase, Serotonin transporter, and tryptophan hydroxylase gene polymorphisms in bipolar disorder patients with and without co-morbid panic disorder","volume":"159","author":"Rotondo","year":"2002","journal-title":"American Journal of Psychiatry"},{"issue":"8","key":"10.1016\/j.jad.2012.07.016_bib44","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.4088\/JCP.v69n0816","article-title":"The use of antidepressants in bipolar disorder","volume":"69","author":"Salvi","year":"2008","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2012.07.016_bib45","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0165-0327(99)00111-1","article-title":"Early and later onset bipolar disorders: two different forms of manic depressive illness?","volume":"58","author":"Schurhoff","year":"2000","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.jad.2012.07.016_bib46","series-title":"The Anxiety Disease","author":"Sheehan","year":"1983"},{"issue":"1","key":"10.1016\/j.jad.2012.07.016_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0447.1993.tb03405.x","article-title":"The relative efficacy of high-dose buspirone and alprazolam in the treatment of panic disorder: a double-blind placebo-controlled study","volume":"88","author":"Sheehan","year":"1993","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"suppl 20","key":"10.1016\/j.jad.2012.07.016_bib48","first-page":"22","article-title":"Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic interview for DSM\u2014IV and ICD\u201410","volume":"59","author":"Sheehan","year":"1998","journal-title":"Journal of Clinical Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2012.07.016_bib49","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jad.2008.10.005","article-title":"Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety","volume":"115","author":"Sheehan","year":"2009","journal-title":"Journal of Affective Disorder"},{"key":"10.1016\/j.jad.2012.07.016_bib50","unstructured":"Sheehan, D.V., 2010. The Sheehan Irritability Scale. \u00a9 1999."},{"issue":"2","key":"10.1016\/j.jad.2012.07.016_bib51","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/YIC.0b013e3282f2b4d6","article-title":"Assessing treatment effects in clinical trials with the discan metric of the Sheehan Disability Scale","volume":"23","author":"Sheehan","year":"2008","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1016\/j.jad.2012.07.016_bib52","unstructured":"Shytle, R.D., Sheehan, D.V., Silver A.A. \u00a9 2002."},{"issue":"12","key":"10.1016\/j.jad.2012.07.016_bib53","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1176\/appi.ajp.161.12.2222","article-title":"Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)","volume":"161","author":"Simon","year":"2004","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jad.2012.07.016_bib54","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"6","key":"10.1016\/j.jad.2012.07.016_bib55","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/j.1399-5618.2006.00371.x","article-title":"Pharmacological treatment of psychiatric comorbidity in bipolar disorder: a review of controlled trials","volume":"8","author":"Singh","year":"2006","journal-title":"Bipolar Disorders"},{"key":"10.1016\/j.jad.2012.07.016_bib56","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0165-1781(97)00123-6","article-title":"Modification of the Clinical Global Impressions scale for use in bipolar illness (BP): the CGI-BP","volume":"73","author":"Spearing","year":"1997","journal-title":"Psychiatry Research"},{"issue":"3","key":"10.1016\/j.jad.2012.07.016_bib57","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1080\/15622970701317265","article-title":"Quetiapine for the treatment of bipolar II depression: analysis of data from two randomized, double-blind, placebo-controlled studies","volume":"9","author":"Suppes","year":"2008","journal-title":"World Journal of Biological Psychiatry"},{"issue":"7","key":"10.1016\/j.jad.2012.07.016_bib58","doi-asserted-by":"crossref","first-page":"870","DOI":"10.4088\/JCP.v66n0710","article-title":"The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder","volume":"66","author":"Suppes","year":"2005","journal-title":"Journal of Clinical Psychiatry"},{"issue":"6","key":"10.1016\/j.jad.2012.07.016_bib59","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/01.jcp.0000248603.76231.b7","article-title":"Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study","volume":"26","author":"Thase","year":"2006","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"1\u20133","key":"10.1016\/j.jad.2012.07.016_bib60","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jad.2007.03.014","article-title":"Effect of comorbid anxiety on treatment response in bipolar depression","volume":"104","author":"Tohen","year":"2007","journal-title":"Journal of Affective Disorders"},{"issue":"2","key":"10.1016\/j.jad.2012.07.016_bib62","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/ebmh.12.2.49","article-title":"Review: long term use of antidepressants for bipolar disorder reduces depressive episodes but increases risk of mania","volume":"12","author":"Young","year":"2009","journal-title":"Evidence-Based Mental Health"},{"issue":"1","key":"10.1016\/j.jad.2012.07.016_bib63","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0165-0327(93)90118-4","article-title":"Anxious and nonanxious bipolar disorder","volume":"29","author":"Young","year":"1993","journal-title":"Journal of Affective Disorder"},{"key":"10.1016\/j.jad.2012.07.016_bib64","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity, and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"British Journal of Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032712005356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032712005356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:11:33Z","timestamp":1759021893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032712005356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0165032712005356"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2012.07.016","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomized, placebo-controlled trial of quetiapine XR and divalproex ER monotherapies in the treatment of the anxious bipolar patient","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2012.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}